Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Jan 04, 2021

Fosun Buys Chinese Baijiu Maker for $694 Million in Local Pivot

STOCKS IN THIS STORY
Goenka Business & Finance Ltd.
--
Cosco (India) Ltd.
--
Nifty Capital Markets
--
Nifty Top 20 Equal Weight
--
MSCI World
--
Pritika Auto Industries Ltd
--
Cons Discretionary Goods & Serv
--
MSCI AC Asia ex-Japan
--
Kanishk Steel Industries Ltd.
--
BSE Healthcare
--

Fosun International Ltd. is acquiring a controlling stake in Sichuan Tuopai Shede Group Co., boosting its presence in the coveted baijiu liquor sector as the Chinese conglomerate led by billionaire Guo Guangchang pivots inward for growth.

Fosun will buy a 70% stake in the liquor and spirits maker for 4.53 billion yuan ($694 million) in cash, the company said in a Dec. 31 exchange filing. This is the second such investment in 2020 by the Fosun Group after it bought a 30% stake in another maker of the fiery wine -- a hot favorite in China -- in July.

The transaction underscores the domestic push underway at the insurance-to-tourism conglomerate as the Chinese economy rebounds from a pandemic-induced slowdown, even as western nations still struggle to contain the coronavirus outbreak.

Fosun is “optimistic about the potential growth of the target company which operates a high-quality liquor and spirits business,” it said in the filing, adding that the deal will cement its foothold in businesses which “support the lifestyle” of modern Chinese consumers.

Asset-Price Downturn

Its founder Guo said in March that it will seek out investment opportunities as the “once-in-a-century” coronavirus pandemic sparks an asset-price downturn. Fosun is one of the largest and last remaining acquisitive Chinese groups. Its businesses span health care, insurance, tourism and leisure, and about 45% of its revenue was from overseas in 2019.

The pandemic, which forced people to stay home for months and shun travel, hit Fosun's tourism and retail businesses the hardest, Guo told Bloomberg Television in August. It lost its 20% stake in the struggling circus operator, Cirque du Soleil Entertainment Group the same month.

Fosun Chief Sees Profit Rebound to ‘Normal' Levels Next Year

The conglomerate is now betting on its pharmaceuticals division to offset the slump as its unit Shanghai Fosun Pharmaceutical Group Co. gears up to market Pfizer-BioNTech's coronavirus vaccine in Hong Kong.

©2021 Bloomberg L.P.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search